PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.\', \'Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.\', \'Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'ID Pharma Co., Ltd., Ibaraki 300-2611, Japan.\', \'Management Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1016/j.xcrm.2022.100520
?:doi
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 35233545
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all